FDA panel votes to ease restrictions on an unregulated peptide BPC-157

The FDA voted by committee to ease restrictions on BPC-157, a popular peptide among influencers who market peptides as an effective treatment for weight loss, immunity and skin health. NBC News' Erika Edwards reports.

For more context and news coverage of the most important stories of our day, click here: https://www.nbcnews.com

» Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC » Subscribe to Here's the Scoop podcast: https://www.nbcnews.com/heres-the-scoop-daily-podcast » NBC News App: https://apps.nbcnews.com/mobile » Breaking News Alerts: https://link.nbcnews.com/join/5cj/breaking-news-signup?cid=sm_npd_nn_yt_bn-clip_190621 » Visit NBCNews.Com: http://nbcnews.to/ReadNBC » Find NBC News on Facebook: http://nbcnews.to/LikeNBC » Follow NBC News on Twitter: http://nbcnews.to/FollowNBC » Follow NBC News on Instagram: http://nbcnews.to/InstaNBC